» Articles » PMID: 7859937

Proinsulin As a Marker for the Development of NIDDM in Japanese-American Men

Overview
Journal Diabetes
Specialty Endocrinology
Date 1995 Feb 1
PMID 7859937
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Disproportionate hyperproinsulinemia is one manifestation of the B-cell dysfunction observed in non-insulin-dependent diabetes mellitus (NIDDM), but it is unclear when this abnormality develops and whether it predicts the development of NIDDM. At baseline, measurements of proinsulin (PI) and immunoreactive insulin (IRI) levels were made in 87 second-generation Japanese-American men, a population at high risk for the subsequent development of NIDDM, and, by using World Health Organization criteria, subjects were categorized as having normal glucose tolerance (NGT; n = 49) or impaired glucose tolerance (IGT; n = 38). After a 5-year follow-up period, they were recategorized as NGT, IGT, or NIDDM using the same criteria. After 5 years, 16 subjects had developed NIDDM, while 71 had NGT or IGT. Individuals who developed NIDDM were more obese at baseline, measured as intra-abdominal fat (IAF) area on computed tomography (P = 0.046) but did not differ in age from those who continued to have NGT or IGT. At baseline, subjects who subsequently developed NIDDM had higher fasting glucose (P = 0.0042), 2-h glucose (P = 0.0002), fasting C-peptide (P = 0.0011), and fasting PI levels (P = 0.0033) and disproportionate hyperproinsulinemia (P = 0.056) than those who continued to have NGT or IGT after 5 years of follow-up. NIDDM incidence was positively correlated with the absolute fasting PI level (relative odds = 2.35; P = 0.0025), even after adjustment for fasting IRI, IAF, and body mass index (relative odds = 2.17; P = 0.013).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin.

Parsons V, Vadlamudi S, Voos K, Rohy A, Moxley A, Cannon M Diabetologia. 2025; .

PMID: 40064677 DOI: 10.1007/s00125-025-06391-w.


Insulin receptor isoform B is required for efficient proinsulin processing in pancreatic β cells.

Jiang M, Wang N, Zhang Y, Zhang J, Li Y, Yan X iScience. 2024; 27(7):110017.

PMID: 39021804 PMC: 11253548. DOI: 10.1016/j.isci.2024.110017.


Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing.

Meier D, Rachid L, Wiedemann S, Traub S, Trimigliozzi K, Stawiski M Nat Commun. 2022; 13(1):4761.

PMID: 35963866 PMC: 9376086. DOI: 10.1038/s41467-022-32509-4.


Endoplasmic Reticulum (ER) Stress and Its Role in Pancreatic β-Cell Dysfunction and Senescence in Type 2 Diabetes.

Lee J, Lee J Int J Mol Sci. 2022; 23(9).

PMID: 35563231 PMC: 9104816. DOI: 10.3390/ijms23094843.


The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.

Kahn S, Chen Y, Esser N, Taylor A, van Raalte D, Zraika S Endocr Rev. 2021; 42(5):528-583.

PMID: 34180979 PMC: 9115372. DOI: 10.1210/endrev/bnab021.